Natural Killer(NK) Cell Therapy for Acute Myeloid Leukemia
Clinical trial NCT05601466 · TERMINATED
Trial details
- NCT number
- NCT05601466
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-26
- Primary completion
- 2023-04-11
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.